Apr 6, 2026
Apr 6, 2026
Apr 6, 2026
Apr 6, 2026
Apr 6, 2026
Apr 6, 2026
Apr 6, 2026
Apr 6, 2026
Grail, a key player in the healthcare sector, saw its shares plummet by 45.6% in February. This drop followed the release of underwhelming results from its multi-cancer screening test, Galleri, conducted with England's NHS.